September/October 2026

September/October 2026

Volume 24, Issue 4

Browse other Issues

Subscribe to our eNewsletter

Download Issue »

Articles in this Issue

  • Can OSD Handle the GLP-1 Appetite?

    Can OSD Handle the GLP-1 Appetite?

    September 25, 2026
    The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s.
  • A Consistent Standard for Dust Safety

    A Consistent Standard for Dust Safety

    September 29, 2026
    The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than introducing an entirely new philosophy, NFPA 660 consolidates several legacy combustible dust standards into one comprehensive document, providing a consistent framework for evaluating combustible dust hazards across all industries.
  • From Shore to Shore

    From Shore to Shore

    September 29, 2026
    More than six decades after Hovione’s humble basement beginnings, the company is still betting on the value of being global. But today, that means something different. It’s not simply about having manufacturing sites around the world. It’s about making those sites work both together and independently.
  • From Molecule to Patient Impact

    From Molecule to Patient Impact

    October 13, 2026
    Closing the non-adherence gap will require closer collaboration across the healthcare ecosystem, bringing together formulation scientists, excipient specialists, drug developers, regulators, clinicians and technology partners earlier in development.